Ligand · 42Q
42Q · 1-{2-fluoro-4-[(5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)oxy]phenyl}-3-[3-(trifluoromethyl)phenyl]urea
42Q, 1-{2-fluoro-4-[(5-methyl-5H-pyrrolo[3,2-d]pyrimidin-4-yl)oxy]phenyl}-3-[3-(trifluoromethyl)phenyl]urea (C21 H15 F4 N5 O2, 445.4 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1 PDB entry). Every binding site with…
- Component
- 42Q
- Formula
- C21 H15 F4 N5 O2
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
42Q in 2 structures; the first of them:
- 3VHE · Crystal structure of human VEGFR2 kinase domain with a novel pyrrolopyrimidine inhibitor. · 42Q A1170 · binds LEU840, VAL848, ALA866, LYS868, GLU885, ILE888, LEU889, ILE892 and 15 more
- 3VHE · Crystal structure of human VEGFR2 kinase domain with a novel pyrrolopyrimidine inhibitor. · 42Q A1170 · binds LEU840, VAL848, ALA866, LYS868, GLU885, ILE888, LEU889, ILE892 and 15 more
Residues it binds most
VAL 2, LEU 2, ILE 2, CYS 2, GLU 2, PHE 2, ALA 2, ASP 2, GLY 2, HIS 2 (residue and the binding sites it lines).
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.